| Stats | Twitter歴 4,493日（2009/04/14より） |
ツイート数 70,496（15.6件/日） |
表示するツイート :
Naoto T Ueno, MD, PhD@teamoncology
A great honor to be invited to this important meeting. I talked about the RTK signaling pathway (EGFR, JNK) regulating the immunosuppression status. Targeting the tumor microenvironment by EGFR or JNK inhibitor may enhance immunotherapy in TNBC & IBC.
https://www.kwcs.jp/jamr2021/english.html…
posted at 11:21:48
Naoto T Ueno, MD, PhD@teamoncology
Neoadjuvant Therapy in TNBC. Higher TCR clonality, PD-L1 positivity, higher CD3+:CD68+ ratio, and closer spatial proximity of T-cells to tumor cells predicted pCR. The closer the T-cells to tumor cells and PD-L1 expression enhanced pCR prediction. https://clincancerres.aacrjournals.org/content/early/2021/07/09/1078-0432.CCR-21-0144…
posted at 10:45:30
Naoto T Ueno, MD, PhD@teamoncology
Thanks for the opportunity to speak at the Japan Metastasis Society Annual Meeting. https://twitter.com/teamoncology/status/1415027592600506369…
posted at 16:00:21
Naoto T Ueno, MD, PhD@teamoncology
Is this a surprise? Nope. Unvaccinated people, you are doing a disservice because of prolonging the pandemic. The more uncontrolled period, more likely that new variants could rise. https://twitter.com/cdcgov/status/1420104200957038594…
posted at 17:48:03
Naoto T Ueno, MD, PhD@teamoncology
.@QueensMedical congrats for recognizing as top 50 cancer care by @usnews @USNewsHealth. Leading the cancer care in Hawaii. @MDAndersonNews partner.
posted at 12:16:43
Naoto T Ueno, MD, PhD@teamoncology
It is good to hear science decide about the use of masks. However, we need to remember that science does not drive human behavior. A simple and clear message of masking can be implemented until truly the pandemic calms down. Just my two cents. https://twitter.com/NPR/status/1420063122522615809…
posted at 07:04:30
Naoto T Ueno, MD, PhD@teamoncology
FDA approved the use of pembrolizumab in high-risk early triple-negative breast cancer. A major practice change. Major adjustment is needed with our standard of care and existing ongoing neoadjuvant and adjuvant clinical trials. #bcsm
https://www.merck.com/news/fda-approves-keytruda-pembrolizumab-for-treatment-of-patients-with-high-risk-early-stage-triple-negative-breast-cancer-in-combination-with-chemotherapy-as-neoadjuvant-treatment-then-continued/…
posted at 06:38:49
Naoto T Ueno, MD, PhD@teamoncology
Yeah. Congratulations!! https://twitter.com/hawaiinewsnow/status/1419936580047937559…
posted at 20:37:44
Naoto T Ueno, MD, PhD@teamoncology
MD Anderson was selected as no. 1 best hospital by U.S. News & World Report’s annual “Best Hospitals” rankings. Proud to be a member of the hospital. All my education, my career, and my patient care reside in this cancer center.
https://health.usnews.com/best-hospitals/rankings/cancer…
posted at 17:08:42
Naoto T Ueno, MD, PhD@teamoncology
Very proud of Japan 🇯🇵!! https://twitter.com/tokyo2020/status/1419913094067679237…
posted at 16:44:45
Naoto T Ueno, MD, PhD@teamoncology
Summer Collection of Tempura. Do you feel the summer by these ingredient? Sweet fish, myoga, Japanese green pepper, asparagus. If you do, you are very Japanese. :) https://pic.twitter.com/ymQw7VQTvJ
posted at 14:52:18
Naoto T Ueno, MD, PhD@teamoncology
It is amazing to see a post-allogeneic stem transplant for leukemia now competing for the Olympics after only several years. Go Ms. @rikakoikee. Respect from ex-transplant doc and stem transplant recipient.
https://news.line.me/issue/oa-sankeinews/iy38y607rtmg?mediadetail=1%3Futm_source%3Dline&utm_medium=share&utm_campaign=none&fbclid=IwAR1sPsj-7IyIMp06cjwiXmWmhoGRhR6iU_9de-1rhw5hIZGdQzvJ_dLacsA…
posted at 07:02:19
Naoto T Ueno, MD, PhD@teamoncology
The data suggest that there is no reason to de-escalate the treatments for inflammatory breast cancer because of age. #bcsm #talkIBC
https://link.springer.com/article/10.1245/s10434-021-10453-9…
posted at 06:59:17
Naoto T Ueno, MD, PhD@teamoncology
1964 Tokyo Olympics was showing the economic strength of the postwar recovery. 2021 shows the new Japan, harmony of tradition and diversity. Well done Japan. https://www.nytimes.com/2021/07/23/sports/olympics/naomi-osaka-lights-cauldron.html…
posted at 09:20:30
Naoto T Ueno, MD, PhD@teamoncology
A great choice. She represent Japan’s future. Diversity and Inclusiveness. https://twitter.com/gmasportsph/status/1418584559164084227…
posted at 23:53:08
Naoto T Ueno, MD, PhD@teamoncology
@mittallab Sigh
posted at 15:02:26
Naoto T Ueno, MD, PhD@teamoncology
The original 2017 paper that Senator Rand Paul accusing that NIH has supported the functional gain to enhance the virulence activity of Coronavirus.
https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1006698…
It sure does not read like functional gain experiments.
Dr. Fauci is correct.
posted at 13:42:18
Naoto T Ueno, MD, PhD@teamoncology
【The Zeta Tau Alpha Houston Alumnae Association Fellowship in Inflammatory Breast Cancer Research】 We will award two travel awards, $1,000 each.
You can download the application and the instruction from the below link. Please apply and RT.
https://www.dropbox.com/s/2xxr6ymbn2tfha9/FW__The_2021_Zeta_Tau_Alpha_Houston_Alumnae_Association_Fellowship_in_Inflammatory_Breast_Cancer_Research_-_Call_for_Abstracts_-_Due_August_31%2C_2021.zip?dl=0…
posted at 11:28:38
Naoto T Ueno, MD, PhD@teamoncology
最高の医療を引き出すための患者力とは(オンライン講座)を 昭和大学リカレントカレッジが10月から全5回で開催致します。是非お申し込みください。よろしくお願いいたします。 https://recurrent.showa-u.ac.jp/course/detail/58/…
posted at 16:39:24
Naoto T Ueno, MD, PhD@teamoncology
The ridiculous thing that I have heard recently. The discrimination issue impacts everyone, and it is not associated with the country that you represent. https://www.insider.com/naomi-osaka-japan-olympics-games-over-usa-netflix-documentary-2021-7…
posted at 06:26:24
Naoto T Ueno, MD, PhD@teamoncology
Sigh. We still need Olympic under pandemic? https://twitter.com/japantoday/status/1416651717794357251…
posted at 20:47:24
Naoto T Ueno, MD, PhD@teamoncology
Tattoo ink can be mistaken as lymph node involvement by breast cancer—something to keep in mind. Tatoo does not cause cancer, but you can get a false positive reading.
https://www.today.com/health/more-people-have-tattoos-doctors-see-ink-mammograms-t225645…
posted at 11:15:52
Naoto T Ueno, MD, PhD@teamoncology
Here is the formal interim update of KEYNOTE-522 by Merck. We have a new standard of care. Use of checkpoint inhibitor with chemo for early TNBC.
https://www.merck.com/news/keytruda-pembrolizumab-plus-chemotherapy-before-surgery-and-continued-as-a-single-agent-after-surgery-showed-statistically-significant-event-free-survival-efs-result-versus-neoadjuvant-chemo/…
posted at 08:57:07
Naoto T Ueno, MD, PhD@teamoncology
Now that we have EFS difference (HR=0.67 [95% CI, 0.49-0.92]). Why is the HR better in CPS < 1 compared to CPS≥1 (0.48 vs 0.67). We should not compare but I like to compare for hypothesis generation. https://twitter.com/PTarantinoMD/status/1415737021713289219…
posted at 08:55:01
Naoto T Ueno, MD, PhD@teamoncology
Applied for an astronaut. My childhood dream going to space. Now, I want to show that cancer survivors can challenge anything.
https://spaceforhumanity.typeform.com/to/tn5Q9hKX
posted at 08:27:06
Naoto T Ueno, MD, PhD@teamoncology
Why are some people are so selfish?
https://news.yahoo.com/once-beloved-pandemic-pets-now-190939025.html…
posted at 19:35:44
Naoto T Ueno, MD, PhD@teamoncology
このサービスがアメリカの多くのレストランのテイクアウトには無いんだよね。わかりますか。 https://pic.twitter.com/0i0tWqdcmN
posted at 14:01:16
Naoto T Ueno, MD, PhD@teamoncology
Illuminating Hope for our patients with inflammatory breast cancer (IBC). Our quarterly newsletter. Please feel free to spread the newsletter. Click to download.
https://www.dropbox.com/s/7ytnnrnwaeeu9ce/Iluminating%20Hope%20-%20Issue%2024%20July%202021.pdf?dl=0…
posted at 08:29:03
Naoto T Ueno, MD, PhD@teamoncology
An interesting move from France, will this come to the USA, it may not come from the federal gov but I can see from the hospitals after the FDA gives full approval of the vaccine.
https://www.reuters.com/world/europe/france-make-covid-19-vaccination-mandatory-health-workers-macron-2021-07-12/…
posted at 05:57:24
Naoto T Ueno, MD, PhD@teamoncology
What do you think? Can you refuse? Please remember docs have different levels of the immune system, this means that there are docs who may need to take more extra measure who is not vaccinated or symptomatic. https://www.nytimes.com/2021/07/13/magazine/vaccination-patients-ethics.html?smid=tw-share…
posted at 13:20:02
Naoto T Ueno, MD, PhD@teamoncology
The online 1st by Takashi S et al. reports on the clinical relevance of inflammatory pathway JNK in the immunosuppressive status of TNBC by regulating CCL-2 production from macrophages. Thus, JNK is an important target to improve immunotherapy efficacy.
https://academic.oup.com/jnci/advance-article/doi/10.1093/jnci/djab128/6313157?guestAccessKey=003161b8-b20e-49fc-beb0-f5326570412f… https://pic.twitter.com/F8uM8whMQu
posted at 04:17:22
Naoto T Ueno, MD, PhD@teamoncology
The ERK pathway can be regulated by master switch PEA-15. This ERK regulation can lead to a tumor microenvironment that suppresses the aggressiveness of triple-negative #breastcancer. #endcancer
Congratulations to Dr. @cbartholomeusz1 and her colleagues. https://pubmed.ncbi.nlm.nih.gov/34241740/
posted at 04:45:09
Naoto T Ueno, MD, PhD@teamoncology
An earThe bottom line is for you to get the vaccine regardless of your risk factors. Wear your mask and continue social distracting until the pandemic is entirely over. https://www.cell.com/cancer-cell/fulltext/S1535-6108(21)00330-5…
posted at 22:48:13
Naoto T Ueno, MD, PhD@teamoncology
An early data of how well you will develop immunogenicity to protect yourself from COVID-19. For most cancer patients, the vaccine is effective. The risk is higher with those with blood cancer, active chemotherapy, and the use of rituximab. https://www.cell.com/cancer-cell/fulltext/S1535-6108(21)00330-5…
posted at 22:47:40
Naoto T Ueno, MD, PhD@teamoncology
説明責任を問うのはいいと思うが、外国人を召喚できるだけの国会の力は無いと思う。夢物語。 https://twitter.com/shiikazuo/status/1413314490054057985…
posted at 15:00:22
Naoto T Ueno, MD, PhD@teamoncology
@StockwellSerena @medpagetoday Thanks for spreading the info!!
posted at 22:20:38
Naoto T Ueno, MD, PhD@teamoncology
I am grateful to @ConquerCancerFd @ASCO for the opportunity. I have learned a lot from the interaction with our colleagues in different parts of the world! https://twitter.com/ConquerCancerFd/status/1412494096845914121…
posted at 00:58:52
Naoto T Ueno, MD, PhD@teamoncology
Thanks, Sage Patient Advocate @TNBCFoundation for posting about Best Practices for Palliative Care for Patients With Metastatic Breast Cancer. We all want to provide the best quality of life. This article talks about what patients and families can do.
https://forum.tnbcfoundation.org/topic13821_post135972.html#135972…
posted at 00:56:50
Naoto T Ueno, MD, PhD@teamoncology
An interesting paper, inflammatory tumor microenvironment contributing to the aggressiveness of breast cancer. https://twitter.com/NatureComms/status/1409473792846467074…
posted at 03:55:25
Naoto T Ueno, MD, PhD@teamoncology
Spending more time to understand physician and APN burnout issues via @AmerMedicalAssn. Also, taking @MDAndersonNews @ProjectECHO to learn about things that matters and the action that we need to embrace. A tough topic to tackle. https://www.ama-assn.org/topics/physician-burnout…
posted at 21:07:11
Naoto T Ueno, MD, PhD@teamoncology
"Journal of Cancer" impact factor is now 4.207. As editor-in-chief, we thank all the authors and editors who contributed to advancing the journal. We are always seeking high-quality clinical, translational, and basic research papers.
https://www.jcancer.org
posted at 21:01:41
Naoto T Ueno, MD, PhD@teamoncology
@MelanconTess @MDAndersonNews @DianeBodurka @cbartholomeusz1 Thanks for joining the session. I hope that it was helpful for the participants.
posted at 20:51:15
Naoto T Ueno, MD, PhD@teamoncology
Reply to: “Real-world prevalence across 159,872 patients with cancer supports the clinical utility of TMB-H to define metastatic solid tumors for treatment with pembrolizumab.” by D. Fabrizio et al. https://www.annalsofoncology.org/article/S0923-7534(21)02066-4/fulltext#.YNhVA0Zlrlo.twitter…
posted at 19:38:02
Naoto T Ueno, MD, PhD@teamoncology
In May, 99.2% of 18,000 COVID-19 death was those who did not have the vaccine. More reason why you need to get a vaccine to help yourself and to stop the pandemic.
https://apnews.com/article/coronavirus-pandemic-health-941fcf43d9731c76c16e7354f5d5e187…
posted at 03:25:21
Naoto T Ueno, MD, PhD@teamoncology
posted at 03:17:44
Naoto T Ueno, MD, PhD@teamoncology
IBC survivor is grateful for clinical trials. Thank you for your partication. Clinical trials are essential for the advancement of cancer treatment and diagnosis. Rare and aggressive breast cancer such as IBC needs more support for innovative approaches. https://www.mdanderson.org/cancerwise/i-am-still-here--inflammatory-breast-cancer-survivor-is-grateful-for-clinical-trials.h00-159461634.html#.YNdLQtZ2214.twitter…
posted at 00:45:04
Naoto T Ueno, MD, PhD@teamoncology
Defining the skills, we will need in the future world of work https://mck.co/35RyehC via @McKinsey. I absolutely enjoyed reading this article. More to learn to self-develop yourself to become a great leader and a great team member.
posted at 00:24:58
Naoto T Ueno, MD, PhD@teamoncology
If you suspect the breast implant rupture, you are supposed to order MRI without contrast. If you are looking for breast cancer or infection, you need contrast, Without contrast, you may miss the diagnosis of cancer. Something that I have learned today. #bcsm
posted at 06:29:43
Naoto T Ueno, MD, PhD@teamoncology
Are you a Mac fan? I am. I got my first Mac in 84. I love this remastered Macintosh ad. Enjoy the video. https://youtu.be/-6cFUvABwp4
posted at 03:37:06
Naoto T Ueno, MD, PhD@teamoncology
I appreciate @ASCO the opportunity to work with a med oncologist from Bangladesh. Working with Dr. Islam taught me how fortunate we are with what we have. Gives me more motivation to help. First time to have a formal virtual visitor at @MDAndersonNews.
https://connection.asco.org/blogs/doing-what-i-can-what-i-have-where-i-am-perspective-medical-oncologist-bangladesh…
posted at 20:10:08
